Loading BioAtlas...
Loading BioAtlas...
Compare biological models, docking engines, and computational workflows side-by-side. Filter by access model, compute footprint, and category to reach an actionable decision table in under a minute.
| Attribute | ＋ Add tool | |
|---|---|---|
| Category | Research Cloud & Data Platforms | — |
| Subcategory | Cloud Genomics & Biomedical Data Platforms | — |
| Company | Broad Institute, Microsoft & Verily | — |
| Access mode | Pay-as-you-go Cloud Compute | — |
| Licence conditions | Open platform; users pay underlying cloud compute and storage costs | — |
| Compute requirements | Google Cloud Platform (GCP) or Microsoft Azure backend | — |
| Biological application | Population genomics, GWAS, clinical variant discovery, and multi-omics integration | — |
| Research workflow | Secure dataset cohort selection -> pipeline execution at cloud scale -> interactive statistical analysis | — |
| Evidence level | Infrastructure backbone for major international biomedical consortia | — |
| Commercial eligibility | Available for academic research and commercial organizations | — |
| Price | Free platform access — pay cloud infrastructure costs | — |
| Availability ⓘ | Available globally on Google Cloud and Microsoft Azure | — |
| Features | Direct secure access to controlled biomedical repositories (All of Us, BioData Catalyst, AnVIL), Scalable execution of WDL (Workflow Description Language) pipelines via Cromwell engine, Interactive Jupyter and RStudio cloud analysis environments, Strict biomedical compliance (FedRAMP, HIPAA, SOC 2) | — |
| Entry type | Cloud Platform | — |
| AI role | Workflow Execution & Data Governance | — |
| Input data | Not recorded | — |
| Output data | Not recorded | — |
| Validation | Not recorded | — |
| Type | Cloud biomedical analysis platform | — |
| Intended use | Not recorded | — |
| Compatibility | Not recorded | — |
| Manufacturer | Broad Institute of MIT and Harvard | — |
| Integration evidence | https://terra.bio | — |
| Laboratory handoff | Informs clinical trial cohort selection and genetic target validation | — |